Clinical practice: heart failure in children. Part I: clinical evaluation, diagnostic testing, and initial medical

Paul F Kantor1, Luc L Mertens

  • 1Labatt Family Heart Center, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. paul.kantor@sickkids.ca

Insights

Pediatric heart failure is a serious condition, with nearly half of children experiencing it facing poor outcomes within five years. This review offers a diagnostic and initial treatment framework for pediatric heart failure.

Area of Science:

  • Pediatric Cardiology
  • Pediatric Heart Failure
  • Cardiomyopathy in Children

Background:

  • Pediatric cardiomyopathy and symptomatic heart failure carry a high mortality rate, with nearly 50% of affected children dying or needing transplantation within 5 years.
  • Effective management requires a comprehensive approach, including assessing cardiac function, the child's overall condition, and identifying underlying causes.

Purpose of the Study:

  • To provide pediatricians and cardiologists with a structured diagnostic framework for pediatric heart failure.
  • To offer an overview of current treatment options for heart failure in children.
  • To outline initial medical management strategies.

Main Methods:

  • Review of current evidence on pediatric heart failure.
  • Focus on clinical evaluation and diagnostic testing.
  • Discussion of initial medical management strategies.

Main Results:

  • The clinical evaluation of pediatric heart failure involves assessing cardiac appearance and function.
  • Diagnostic testing is crucial for identifying potential root causes.
  • Initial medical management forms the first step in treatment.

Conclusions:

  • A systematic approach to diagnosis and initial management is essential for improving outcomes in children with heart failure.
  • This review provides a foundational framework for clinicians.
  • Part two will cover maintenance and advanced treatment options.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...